View On Demand

The Science of Wellness and Prevention: What Does It Require?

About the Event

Many physicians agree that managing stress biology can improve health and wellness of people with a number of chronic medical conditions. Inmedix has developed an easy to administer test for stress biology that has a total addressable market exceeding $3BN.

Please join a panel discussion on the science of wellness and prevention featuring three distinguished experts in the field:

Andrew J. Holman MD, Co-Founder, CEO Inmedix
Dr. Holman is the founding rheumatologist and Director of Research at Pacific Rheumatology Research Inc. He is former President of the Northwest Rheumatism Society and a Clinical Associate Professor of Medicine at the University of Washington. He has designed, completed and published 15 clinical studies, including FDA negotiations, involving nearly 1500 patients.

Lee Hood, MD PhD, CEO Phenome Health & CSO Institute for Systems Biology
A world-renowned scientist and recipient of the National Medal of Science in 2011, Dr. Leroy Hood is the co-founder of the Institute for Systems Biology, the SVP and Chief Science Officer at Providence St. Joseph Health and Chief Strategy Officer and Professor at ISB. Among his many achievements, Dr. Hood is a member of the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine. Of the more than 6,000 scientists worldwide who belong to one or more of these academies, Dr. Hood is one of only 20 people elected to all three.

Jolene Anderson, co-founder and Managing Partner of Vectorpoint Ventures
Ms. Anderson works with a global client list seeking and an extensive network of business executives and mentors in industry and commerce. She advised companies in the Seattle biotech community and serves on the boards of nonprofits focusing on healthy communities and education. She is a problem solver committed to providing consulting for companies through introducing strategic partnerships and mentorship.

View On-Demand


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.